Building the Multivariate Linear Regression Model of DPP-IV Inhibitors

Building the Multivariate Linear Regression Model of DPP-IV Inhibitors

碩士 === 臺北醫學大學 === 醫學資訊研究所 === 100

Bibliographic Details
Main Authors:	Chung-Fu Wu, 吳重孚
Other Authors:	Yuan-Chii G. Lee
Format:	Others
Language:	zh-TW
Published:	2012
Online Access:	http://ndltd.ncl.edu.tw/handle/19999224791197635235

Similar Items

Biochemical Characterization of Dipeptidyl Peptidase IV (DPP-IV) and DPP9
by: Hung-Kuan Tang, et al.
Published: (2009)

DPP-IV Inhibitor–Associated Angioedema in Patient With Known History of ACE Inhibitor Angioedema
by: Chidinma Ejikeme MD, et al.
Published: (2021-07-01)

3D-QSAR and docking studies of arylmethylamine-based DPP IV inhibitors
by: Chaoyi Jiang, et al.
Published: (2012-08-01)

Comparative analysis of quality of life in patients treated with canagliflozine or DPP-IV inhibitor
by: Nina A. Petunina, et al.
Published: (2016-12-01)

The correlation of the potential of protein hydrolysates as DPP-IV and PEP inhibitors predicted by in silico approaches
by: Chih-Yu Wang, et al.
Published: (2018)

Assessing the binding affinity of a selected class of DPP4 inhibitors using chemical descriptor-based multiple linear regression
by: Jose Isagani Janairo, et al.
Published: (2011-08-01)

Effect of Dipeptidyl Peptidase IV (DPP-4) Inhibitor on the Cardiovascular and Kidney Ultrastructure of the Hyperglycemic Rats
by: Wan-Ru Wang, et al.
Published: (2014)

Analysis of Variance and Hypothesis Testing for Multivariate Local Linear Regression Models
by: Tsai, Chung-Ting, et al.
Published: (2017)

Multivariate Linear Regression Models with Censored and Missing Responses
by: Lung-Shun Lin, et al.
Published: (2016)

Multivariate Function-on-Function Linear Regression
by: Min-Chia Huang, et al.
Published: (2017)

Piperazine sulfonamides as DPP-IV inhibitors: Synthesis, induced-fit docking and in vitro biological evaluation
by: Khalaf Reema Abu, et al.
Published: (2021-12-01)

Evaluation of the potential of dietary proteins as precursors of dipeptidyl peptidase (DPP)-IV inhibitors by an in silico approach
by: Isabelle M.E. Lacroix, et al.
Published: (2012-04-01)

Renoprotective Effects of DPP-4 Inhibitors
by: Daiji Kawanami, et al.
Published: (2021-02-01)

Clinical Use of DPP-4 Inhibitors
by: Baptist Gallwitz
Published: (2019-06-01)

Stimulating β-cell regeneration by combining a GPR119 agonist with a DPP-IV inhibitor.
by: Ansarullah, et al.
Published: (2013-01-01)

Building a Multivariable Linear Regression Model of On-road Traffic for Creation of High Resolution Emission Inventories
by: Powell, James Eckhardt
Published: (2017)

Establishment of a selective evaluation method for DPP4 inhibitors based on recombinant human DPP8 and DPP9 proteins
by: Jinglong Liu, et al.
Published: (2014-04-01)

Adaptive Group Lasso for Multivariate Linear Regression
by: Shing-Hung Yeh, et al.
Published: (2009)

Constructing Takagi-Sugeno Fuzzy System Model by Slip Window and Piecewise Linear Regression Analysis Structure
by: Huang Tai Fu, et al.
Published: (2000)

Topics on Regularization of Parameters in Multivariate Linear Regression
by: Chen, Lianfu
Published: (2012)

Inhibition of dipeptidyl peptidase IV (DPP-IV) by proline containing casein-derived peptides
by: Alice B. Nongonierma, et al.
Published: (2013-10-01)

Sitagliptin: the world’s first DPP-4 inhibitor
by: N. A. Petunina, et al.
Published: (2019-08-01)

Diabetes and bone. Focus on DPP-4 inhibitors
by: A. Y. Babenko, et al.
Published: (2015-12-01)

Investigating the Different Dimensions of DPP-4 Inhibitors
by: Heinz Drexel, et al.
Published: (2014-10-01)

Comparative effectiveness and safety of DPP-4 inhibitors
by: Mamza, Jil Billy
Published: (2016)

A general results for variable selection in multivariate linear regression models
by: Kuo-Chuan Liu, et al.
Published: (1994)

Rapid Identification of Dipeptidyl Peptidase-IV (DPP-IV) Inhibitory Peptides from Ruditapes philippinarum Hydrolysate
by: Rui Liu, et al.
Published: (2017-10-01)

The Main Strategies of Generic Companies in Taiwan Against The Implementation of The Patent Linkage System.
by: WU, CHUNG-FU, et al.
Published: (2019)

Modeling Construction Unit Rate Estimation Using Multivariate Linear Regression Analysis
by: Wen-wei Lee, et al.
Published: (2002)

Clinical aspects and prospects of using DPP-4 inhibitors
by: E. V. Biryukova
Published: (2019-08-01)

Alogliptin – the new member of DPP-4 inhibitors class
by: Nina Aleksandrovna Petunina, et al.
Published: (2014-12-01)

Detection of outliers in a multivariate linear regression model using Gibbs observation.
by: Mohammad Natheer Ismael Kasim, et al.
Published: (2013-03-01)

Dipeptidyl Peptidase (DPP)-IV Inhibitors with Antioxidant Potential Isolated from Natural Sources: A Novel Approach for the Management of Diabetes
by: Anand-Krishna Singh, et al.
Published: (2021-06-01)

Elevated Dipeptidyl Peptidase IV (DPP-IV) Activity in Plasma from Patients with Various Lysosomal Diseases
by: Agnieszka Ługowska, et al.
Published: (2021-02-01)

Chromogenic detection of dipeptidyl peptidase IV (DPP-IV) activity using peptide-functionalized gold nanoparticles
by: Aldewachi, Hasan
Published: (2017)

Dipeptidyl peptidase IV (DPP-IV) inhibitory properties of camel milk protein hydrolysates generated with trypsin
by: Alice B. Nongonierma, et al.
Published: (2017-07-01)

Predicting the DPP-IV Inhibitory Activity pIC50 Based on Their Physicochemical Properties
by: Tianhong Gu, et al.
Published: (2013-01-01)

Effects of DPP-4 inhibitors on the heart in a rat model of uremic cardiomyopathy.
by: Lyubov Chaykovska, et al.
Published: (2011-01-01)

Renal Effects of DPP-4 Inhibitors: A Focus on Microalbuminuria
by: Martin Haluzík, et al.
Published: (2013-01-01)

Alogliptin: a new addition to the class of DPP-4 inhibitors
by: Radha Andukuri, et al.
Published: (2009-07-01)

Cannot write session to /tmp/vufind_sessions/sess_mk976jqtmp1barapr1hikmhr1v